$403,000 Federal Contract Awarded to 3D Imaging Drug Design& Development

Targeted News Service |

By Targeted News Service WASHINGTON, June 26 -- 3D Imaging Drug Design& Development, North Little Rock, Arkansas, won a $403,000 federal contract from the U.S. Department of Health and Human Services' Food and Drug Administration, Rockville, Maryland, for radioactive-labeled tracer synthesis. For more information about Targeted News Service's products, including its daily federal contract report, please contact: Myron Struck, Myron@targetednews.com, Editor, Targeted News Service LLC, Springfield, Va., Direct: 703/866-4708, Cell: 703/304-1897. 30VitinMar140626-mv-742438 30VitinMar

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
SPOMD SPOM Spo Global Inc n/a n/a n/a n/a

Comments

Can the Media Solve the Partisan Conflict?

Andrew McCarthy, Contributing Editor, The National Review; Michael Zeldin, CNN Legal Analyst; Celeste Katz, Senior Political Reporter, Glamour; Silvia Davi, SVP, Contributing Editor, Equities.com; and Doug Simon, CEO, D S Simon Media discuss how the media’s role has shaped the landscape for communicators and what the media is trying to do to reduce discord in society.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.